お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:マイクロアレイバイオチップの世界市場:2020年~2024年
市場調査レポート
商品コード
981782

マイクロアレイバイオチップの世界市場:2020年~2024年

Global Microarray Biochips Market 2020-2024

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.11円
マイクロアレイバイオチップの世界市場:2020年~2024年
出版日: 2020年12月30日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のマイクロアレイバイオチップの市場規模は、2020年から2024年の間に102億2000万米ドル成長し、予測期間中は20%のCAGRで成長する見込みです。

市場は、コラボレーション戦略による市場プレゼンスの向上、個別化医療の使用増加によって推進されています。

当レポートでは、マイクロアレイバイオチップの世界市場を調査し、市場情勢や規模、ファイブフォース分析、用途別の市場セグメンテーション、顧客や地域別情勢、ベンダー情勢、ベンダー分析などの情報を提供しています。

目次

エグゼクティブサマリー

市場情勢

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 2019年の市場規模
  • 市場の見通し:2019年から2024年の予測

ファイブフォース分析

市場セグメンテーション:用途別

  • 市場セグメンテーション
  • 用途別の比較
  • 創薬・開発:市場規模と予測(2019年~2024年)
  • 診断・治療:市場規模と予測(2019年~2024年)
  • 研究・消耗品:市場規模と予測(2019年~2024年)
  • 法医学:市場規模と予測(2019年~2024年)
  • その他:市場規模と予測(2019年~2024年)
  • 用途別の市場機会

顧客情勢

地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測(2019年~2024年)
  • 欧州:市場規模と予測(2019年~2024年)
  • アジア太平洋:市場規模と予測(2019年~2024年)
  • その他の地域:市場規模と予測(2019年~2024年)
  • 主要国
  • 地域別の市場機会
  • 市場の推進力
  • 市場の課題
  • 市場動向

ベンダー情勢

  • ベンダー情勢
  • 創造的破壊の状況
  • 競合シナリオ

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Agilent Technologies Inc.
  • BioChain Institute Inc.
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Fluidigm Corp.
  • General Electric Co.
  • Illumina Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.

付録

目次
Product Code: IRTNTR46401

Technavio has been monitoring the microarray biochips market and it is poised to grow by $ 10.22 bn during 2020-2024 progressing at a CAGR of 20% during the forecast period. Our report on microarray biochips market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in market presence with collaboration strategy and growing use of personalized medicines. In addition, increase in market presence with collaboration strategy is anticipated to boost the growth of the market as well.

The microarray biochips market analysis includes application segment and geographical landscapes.

Technavio's microarray biochips market is segmented as below:

By Application

  • Drug discovery & development
  • Diagnostics & treatments
  • Research & consumables
  • Forensic medicines
  • Others

By Geographical Landscapes

  • North America
  • Europe
  • APAC
  • ROW

This study identifies rising demand of microarray biochips in genomics and proteomics as one of the prime reasons driving the microarray biochips market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on microarray biochips market covers the following areas:

  • Microarray biochips market sizing
  • Microarray biochips market forecast
  • Microarray biochips market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading microarray biochips market vendors that include Agilent Technologies Inc., BioChain Institute Inc., Bio-Rad Laboratories Inc., Cepheid Inc., Fluidigm Corp., General Electric Co., Illumina Inc., Merck KGaA, PerkinElmer Inc., and Thermo Fisher Scientific Inc.. Also, the microarray biochips market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Application

  • Market segments
  • Comparison by Application
  • Drug discovery and development - Market size and forecast 2019-2024
  • Diagnostics and treatments - Market size and forecast 2019-2024
  • Research and consumables - Market size and forecast 2019-2024
  • Forensic medicines - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Application

Customer Landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor Landscape
  • Landscape disruption
  • Competitive Scenario

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Agilent Technologies Inc.
  • BioChain Institute Inc.
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Fluidigm Corp.
  • General Electric Co.
  • Illumina Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Application - Market share 2019-2024 (%)
  • 22: Comparison by Application
  • 23: Drug discovery and development - Market size and forecast 2019-2024 ($ million)
  • 24: Drug discovery and development - Year-over-year growth 2019-2024 (%)
  • 25: Diagnostics and treatments - Market size and forecast 2019-2024 ($ million)
  • 26: Diagnostics and treatments - Year-over-year growth 2019-2024 (%)
  • 27: Research and consumables - Market size and forecast 2019-2024 ($ million)
  • 28: Research and consumables - Year-over-year growth 2019-2024 (%)
  • 29: Forensic medicines - Market size and forecast 2019-2024 ($ million)
  • 30: Forensic medicines - Year-over-year growth 2019-2024 (%)
  • 31: Others - Market size and forecast 2019-2024 ($ million)
  • 32: Others - Year-over-year growth 2019-2024 (%)
  • 33: Market opportunity by Application
  • 34: Customer landscape
  • 35: Market share by geography 2019-2024 (%)
  • 36: Geographic comparison
  • 37: North America - Market size and forecast 2019-2024 ($ million)
  • 38: North America - Year-over-year growth 2019-2024 (%)
  • 39: Europe - Market size and forecast 2019-2024 ($ million)
  • 40: Europe - Year-over-year growth 2019-2024 (%)
  • 41: APAC - Market size and forecast 2019-2024 ($ million)
  • 42: APAC - Year-over-year growth 2019-2024 (%)
  • 43: ROW - Market size and forecast 2019-2024 ($ million)
  • 44: ROW - Year-over-year growth 2019-2024 (%)
  • 45: Key leading countries
  • 46: Market opportunity by geography ($ million)
  • 47: Impact of drivers and challenges
  • 48: Vendor landscape
  • 49: Landscape disruption
  • 50: Industry risks
  • 51: Vendors covered
  • 52: Market positioning of vendors
  • 53: Agilent Technologies Inc. - Overview
  • 54: Agilent Technologies Inc. - Business segments
  • 55: Agilent Technologies Inc. - Key offerings
  • 56: Agilent Technologies Inc. - Key customers
  • 57: Agilent Technologies Inc. - Segment focus
  • 58: BioChain Institute Inc. - Overview
  • 59: BioChain Institute Inc. - Product and service
  • 60: BioChain Institute Inc. - Key offerings
  • 61: BioChain Institute Inc. - Key customers
  • 62: BioChain Institute Inc. - Segment focus
  • 63: Bio-Rad Laboratories Inc. - Overview
  • 64: Bio-Rad Laboratories Inc. - Business segments
  • 65: Bio-Rad Laboratories Inc. - Key offerings
  • 66: Bio-Rad Laboratories Inc. - Key customers
  • 67: Bio-Rad Laboratories Inc. - Segment focus
  • 68: Cepheid Inc. - Overview
  • 69: Cepheid Inc. - Product and service
  • 70: Cepheid Inc. - Key offerings
  • 71: Cepheid Inc. - Key customers
  • 72: Cepheid Inc. - Segment focus
  • 73: Fluidigm Corp. - Overview
  • 74: Fluidigm Corp. - Business segments
  • 75: Fluidigm Corp. - Key offerings
  • 76: Fluidigm Corp. - Key customers
  • 77: Fluidigm Corp. - Segment focus
  • 78: General Electric Co. - Overview
  • 79: General Electric Co. - Business segments
  • 80: General Electric Co. - Key offerings
  • 81: General Electric Co. - Key customers
  • 82: General Electric Co. - Segment focus
  • 83: Illumina Inc. - Overview
  • 84: Illumina Inc. - Product and service
  • 85: Illumina Inc. - Key offerings
  • 86: Illumina Inc. - Key customers
  • 87: Illumina Inc. - Segment focus
  • 88: Merck KGaA - Overview
  • 89: Merck KGaA - Business segments
  • 90: Merck KGaA - Key offerings
  • 91: Merck KGaA - Key customers
  • 92: Merck KGaA - Segment focus
  • 93: PerkinElmer Inc. - Overview
  • 94: PerkinElmer Inc. - Business segments
  • 95: PerkinElmer Inc. - Key offerings
  • 96: PerkinElmer Inc. - Key customers
  • 97: PerkinElmer Inc. - Segment focus
  • 98: Thermo Fisher Scientific Inc. - Overview
  • 99: Thermo Fisher Scientific Inc. - Business segments
  • 100: Thermo Fisher Scientific Inc. - Key offerings
  • 101: Thermo Fisher Scientific Inc. - Key customers
  • 102: Thermo Fisher Scientific Inc. - Segment focus
  • 103: Currency conversion rates for US$
  • 104: Research Methodology
  • 105: Validation techniques employed for market sizing
  • 106: Information sources
  • 107: List of abbreviations
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.